STRUCTURE

Chairman:
• Dr. Mariano Provencio, Hospital Univ. Puerta de Hierro, Majadahonda, Madrid

Vice-chairman I:
• Dr. Carlos Camps, Hospital General Universitario, Valencia

Vice-chairman II:
• Dr. Enric Carcereny, ICO-Hospital Germans Trias i Pujol, Badalona, Barcelona

Secretary:
• Dr. Bartomeu Massutí, Hospital General Universitario, Alicante

Members:
• Dr. Manuel Cobo, Hospital General Universitario Carlos Haya, Málaga
• Dr. Manuel Dómine, Fundación Jiménez Díaz, Madrid
• Dra. María Rosario García Campelo, Hospital Teresa Herrera, A Coruña
• Dr. José Luis González Larriba, Hospital Clínico San Carlos, Madrid
• Dra. María Guirado, Hospital General de Elche, Alicante
• Dr. Florentino Hernando Trancho, Hospital clínico San Carlos, Madrid
• Dr. Ernest Nadal, ICO-Hospital Duran i Reynals, Hospitalet de Llobregat
• Dr. Delvys Rodríguez, Hospital Insular, Gran Canaria
• Dr. Alfredo Sánchez, Consorcio Hospital Provincial, Castellón
• Dra. Ivana Gabriela Sullivan, Hospital Sant Pau, Barcelona

• Provides a 360-degree overview of emerging trends and challenges in research.
• Advises the GECP on the lines to be pursued in the implementation of clinical trials.
• Detection of major developments in lung cancer.
• Five major areas of work: Research, Clinical, Epidemiological, Surgical and Radiotherapy.

• Rafael Rosell, the ex-chairman of the GECP and current Director of the Personalised Medicine and Cancer Biology Programme at the Instituto Catalán de Oncología Hospital GermansTrias i Pujol, in Badalona and member of the Foundation Council of the EuropeanThoracic Oncology Platform (ETOP).
• Enriqueta Felip, Oncology Department Section Head of Hospital Vall d’Hebron. Felip is a member of the European Society for Medical Oncology (ESMO) and an active member of the International Association for the Study of Lung Cancer (IASLC).
• Alberto Ruano, full accredited professor of Preventive Medicine and Public Health at the University of Santiago de Compostela. Focused on the epidemiology of cancer.
• Florentino Hernando Trancho, head of the Thoracic Surgery Department at the Hospital Clínico San Carlos de Madrid. Hernando Trancho is also an Associate Professor of the Surgery Department at Complutense University of Madrid (UCM).
• MThe final member of this committee is Miguel Angel Molina. Molina has a PhD in Biology and is the Technical Director of the Oncology, Laboratory of the Hospital Universitario Quirón Dexeus, and his work focuses on the development of new tools.

The headquarters of the Spanish Lung Cancer Group (GECP) provides a response to the research needs of the members of the Group, thanks to its more than 15 years’ experience. Its approach, know-how and a solid work and management team composed of professionals with extensive experience in the sector has led to its significant positioning among the scientific and medical community in the development and coordination of research on lung cancer.

Apart from national projects promoted by the GECP, the Headquarters also collaborates, manages and monitors research group international studies in Spain from different countries in which those sites belonging to the GECP actively participate.